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Introduction
The prevention and treatment of diabetes is a public
health concern in many health systems. There is a
substantial literature referring to obesity as a major
risk factor in the development of diabetes. These
studies have used body mass index (BMI) as the
measure of obesity. It is however increasingly recog-
nised that for a given BMI, central rather than lower
body fat distribution, confers greater risk of meta-
bolic and cardiovascular complications of obesity
(1). Schmidt et al. (2) cite studies dating back to
1956 indicating the importance of the association
between waist–hip ratio (WHR) and type 2 diabetes.
The objective of this review was to assess the
quantitative evidence on the relationship between
abdominal obesity and the incidence of type 2 diabe-
tes in both men and women, and to examine the
relative usefulness of different measures of abdominal
obesity.
Method
Comprehensive searches of Medline and Embase
were undertaken by the authors in March 2006,
including an extensive list of subject area key terms.
Studies of human subjects published in English since
1985 were considered. Exclusion criteria were studies
dealing with HIV, hormonal treatment, vitamins or
transplantation, and studies in patients with comor-
bidities at baseline. A total of 119 papers were identi-
ﬁed and screened for relevance by title and abstract.
A subset of 20 relevant papers were then included in
the review.
Studies were included in the review where they
examined the relationship between at least one
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SUMMARY
Background: Quantitative evidence on the strength of the association between
abdominal obesity and the incidence of type 2 diabetes was assessed. Methods:
Systematic review of longitudinal studies assessing the relationship between mea-
sures reﬂecting abdominal obesity and the incidence of type 2 diabetes. Results:
There was a strong association between measures reﬂecting abdominal obesity
and the incidence of type 2 diabetes, the pooled odds ratio was 2.14 (95% CI:
1.70–2.71; p < 0.0001). Waist circumference (WC) was at least as good as other
measures in predicting outcome. Conclusions: There is a strong association
between measures reﬂecting abdominal obesity and the development of type 2
diabetes. Reducing WC may reduce the risk of developing type 2 diabetes.
Review Criteria
• Comprehensive searches of Medline and Embase
undertaken in March 2006. Exclusion criteria
agreed by authors.
• Studies included in the review if they examined
the relationship between at least one measure of
abdominal obesity and development of type 2
diabetes over time.
• Abstracts of all identiﬁed papers assessed by two
reviewers. Inter-rater agreement for study
selection measured using kappa statistic.
• Data from 10 longitudinal studies included in the
quantitative analysis.
Message for the Clinic
• On average, raised abdominal obesity increases
risk of type 2 diabetes more than twofold.
• All measures used to capture abdominal obesity
show a strong relationship to the incidence of
type 2 diabetes.
• Clinicians can use a simple measure of
abdominal obesity to identify patients at
increased risk of developing type 2 diabetes.
• Effective targeting of new drug therapies towards
those at higher risk may be greatly improved by
systematic measurement of waist circumference.
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of type 2 diabetes over time. Measures of abdominal
obesity considered in the review were waist circum-
ference (WC), WHR, iliac circumference (IC) and
intra-abdominal fat area (IAFA). BMI was not con-
sidered a measure of abdominal obesity.
Abstracts of all the identiﬁed papers were assessed
by two reviewers. Inter-rater agreement for study
selection was measured using the kappa statistic. The
weighted kappa was 76.8%, showing a good level of
agreement, and inclusion of the balance of papers
was agreed through discussion on the basis of the
full papers. Hand searching identiﬁed two further
papers.
Data from 10 longitudinal studies reporting the
relation of WHR, WC, IC or IAFA to the develop-
ment of type 2 diabetes on a ratio scale [using odds
ratios (OR) or relative risks] were then included in
the quantitative analysis.
Statistical analysis
We constructed a mixed model to pool the reported
log ratio outcome (e.g. log OR or log-relative risk)
from a total of 15 cohorts reported in these studies.
As studies all estimated the relationship between
measures of abdominal obesity and the development
of diabetes in different ways, we did not attempt to
pool a single ﬁxed relationship but a distribution of
effects and so a random effects analysis was prespeci-
ﬁed. Thus, between study heterogeneity in the deﬁni-
tion of metrics and adjustments for confounding
performed was addressed through deﬁning studies as
random effects. We treated analyses of different mea-
sures of abdominal obesity within a cohort as
repeated measures. Given large sample sizes and
small event rates, the OR approximates closely the
hazard ratio, but to avoid confounding by type of
analysis, we adjusted for risk- or odds-based out-
come. Studies were weighted in the analysis using
the inverse of the within study variance. The princi-
pal analysis was to estimate the pooled effect of
abdominal obesity and the development of diabetes,
regardless of measurement method used. The relative
effectiveness of WC and alternative methods of
measurement, and the potential confounding effect
of length of follow up were estimated directly from
the model. All analyses were conducted in Proc
Mixed, in the sas statistical program (SAS version
9.1, SAS Institute, Cary, NC).
Results
Studies included
Table 1 summarises the characteristics of the stud-
ies used for quantitative analysis. Eight studies (13
cohorts) used fasting and⁄or 2 h glucose tolerance
tests to identify subjects with diabetes, three of
which (four cohorts) also used treatment with dia-
betic medication as an alternative. Two studies
used subject self-reporting, conﬁrmed by random
sampling of medical records. All 15 cohorts in the
analysis were adjusted for age, eight were adjusted
for BMI and most included a range of other
adjustment factors.
Waist and⁄or waist–hip ratio and incidence
of diabetes
All studies showed a positive association between
waist or WHR and incidence of diabetes. Cassano
et al. (3) used a proportional hazards model based
on a prospective evaluation of male participants in
the Department of Veterans Affairs Normative
Aging Study cohort. They found that, after adjust-
ing for age, BMI and cigarette smoking, men in
the top tertile for the ratio of abdominal circum-
ference to hip breadth had a 2.4-fold greater risk
of diabetes than did men in the lowest tertile
(95% CI: 1.7–3.7). When blood glucose was analy-
sed as a continuous outcome variable, the ﬁndings
were consistent, i.e. there was a positive association
with abdominal fat independent of total-body adi-
posity.
Snijder et al. (4) reported data from the Hoorn
study indicating lower OR than Cassano et al., but
with a higher OR in women than men for both
WHR and WC. When adjusted for hip circumference
and BMI or thigh circumference and BMI, the OR
for WC were higher in both men and women, the
highest being 2.66 per one SD larger waist for the
latter adjustment in women.
Wang et al. (5) reported data from the US Health
Professionals Follow-Up Study showing that WC was
better than either BMI or WHR in predicting type 2
diabetes. 83.6% of type 2 diabetes was identiﬁed in
the ﬁfth decile of WC (compared with 82.5% for the
ﬁfth decile of BMI and 74.1% for the ﬁfth decile of
WHR). However, they point out that the inﬂuence
of abdominal fatness on type 2 diabetes is a continu-
ous one so any cut-offs are arbitrary.
In a study of Mexican Americans Wei et al. (6)
found that WC was the best obesity-related predictor
of non-insulin-dependent diabetes, with a predictive
effect equal to that of WHR and BMI combined. The
authors argue that abdominal localisation of body fat
is a more important determinant than total amount
of body fat in this population (mean age 42 for men,
43 for women).
In Japanese Americans McNeely et al. (7) found
that in their younger subgroup aged £ 55 years
(n = 240), a WC greater than or equal to the third
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was associated with diabetes (adjusted relative risk
5.4; 95% CI: 1.7–17.0). This was substantially higher
than their overall ﬁndings for the > 55 and £ 55 age
groups combined.
In Taiwan, Wang et al. (8) reported data showing
a stronger relationship between diabetes incidence
and obesity in women than in men, and indicating
that WC was a better predictor than WHR. However,
for women higher standardised relative risks were
reported for subscapular skinfold thickness (3.07)
and BMI (2.79).
Kaye et al. (9) used participant self-reporting of
diabetes and found that WHR was a signiﬁcant
independent predictor of diabetes in a dose–
response fashion in older women. In addition,
women in the highest tertiles of both WHR
(> 0.878) and BMI (> 29.2 kg⁄m
2) had a 14.4-fold
(95% CI: 9.5–5.6) higher risk than women in the
lowest tertiles.
Carey et al. (10) reported diabetes incidence data
from the US Nurses’ Health Study using participant
self-reporting mechanisms, validated via a random
sample of medical records. They assessed the relative
risk for the 90th percentile of WHR (0.86) vs. the 10th
percentile (0.70) and the 90th percentile of WC
(92 cm) vs. the 10th percentile (67 cm) and concluded
that both measures (as well as BMI) were powerful
independent predictors of type 2 diabetes in US
women.
In particular, Carey et al. (10) argue that WHR
and WC are independent predictors of type 2 diabe-
tes throughout the observed range of values. This
contrasts with previous studies suggesting that mea-
sures of central adiposity might provide additional
information on diabetes risk beyond that provided
0.2 0.5 1 2 5 10 100
Pooled 2.14 (1.70, 2.71)
Boyko 2000_3rd Gen IAFT Both 2.70 (1.50, 4.90)
Boyko 2000_2nd Gen IAFT Both 1.60 (1.10, 2.30)
Chihaoui 2001 IC Male 4.62 (1.68, 12.70)
Chihaoui 2001 IC Female 0.95 (0.30, 2.98)
Wei 1997 WC Male 1.84 (1.13, 3.00)
Wei 1997 WC Female 1.80 (1.40, 2.33)
Wang 2005 WC Male 4.50 (3.00, 6.70)
Wang 1997 WC Male 2.20 (1.54, 3.16)
Wang 1997 WC Female 2.65 (1.90, 3.77)
Snijder 2003 WC Male 1.23 (0.95, 1.64)
Snijder 2003 WC Female 1.98 (1.54, 2.55)
McNeely 2001 WC Both 2.04 (1.61, 2.59)
Carey 1997 WC Female 5.10 (2.90, 8.90)
Wei 1997 WHR Male 1.80 (0.98, 3.31)
Wei 1997 WHR Female 1.72 (1.28, 2.30)
Wang 2005 WHR Male 2.80 (2.10, 3.80)
Wang 1997 WHR Male 1.44 (1.11, 1.87)
Wang 1997 WHR Female 1.76 (1.31, 2.38)
Snijder 2003 WHR Male 1.55 (1.17, 2.06)
Snijder 2003 WHR Female 2.15 (1.63, 2.83)
Kaye 1991 WHR Female 4.60 (3.80, 5.60)
Cassano 1992 WHR Male 3.40 (1.90, 5.90)
Carey 1997 WHR Female 3.10 (2.30, 4.10)
Figure 1 Odds ratios and 95% conﬁdence intervals for incidence of type 2 diabetes
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tral obesity distributions.
Iliac circumference and incidence of diabetes
Chihaoui et al. (11) used IC as the measure of
abdominal obesity. A 10-year prospective study of
subjects aged ‡ 30 living in Tunis showed that IC is
a risk factor for both type 2 diabetes and impaired
glucose tolerance, but multivariate analysis indicated
it was an independent risk factor for conversion to
either condition only in men.
CT scan assessed abdominal fat and incidence
of diabetes
Boyko et al. (12) measured IAFA based on CT scans
in second-generation (nisei) and third-generation
(sansei) Japanese Americans without diabetes, of
whom 22.4% and 5.7%, respectively, developed dia-
betes, as deﬁned by the American Diabetes Associa-
tion (13). In both groups, IAFA was a signiﬁcant
predictor of diabetes incidence even after adjustment
for BMI, total body fat area and subcutaneous fat
area.
Pooled analysis
We included data on 15 independent cohorts from
the 10 included studies in the statistical analysis. All
cohorts were adjusted for age, eight were adjusted
for BMI and most included a range of other adjust-
ment factors.
Figure 1 shows that four cohorts had OR > 4.0,
two using WC [females (10), males (5)], one using
WHR [females (9)] and one using IC [males (11)].
Only one cohort had an OR < 1 [females (11)].
The authors of this paper comment that the large
proportion of their sample lost for follow-up (52%)
may be a source of bias and may consequently have
led to an underestimation of the incidence of type 2
diabetes. Across all the cohorts the pooled OR was
2.14 (95% CI: 1.70–2.71; p < 0.0001) (see Figure 1).
In studies where both WC and WHR were used,
the conﬁdence intervals around the ORs for the two
measures overlapped. In a meta-regression model,
WC was slightly more predictive than other measures
used in the studies although this was not statistically
signiﬁcant [ratio of OR 1.11 (95% CI: 0.88–1.39;
p = 0.32)].
Follow-up periods ranged from 2 to 18 years. The
predictive value of abdominal obesity reduced
slightly with follow up, although this was not statisti-
cally signiﬁcant [ratio of OR 0.76 (95% CI: 0.47–
1.25; p = 0.24)].
There was no evidence of a gender speciﬁc effect
(p = 0.28). We examined the potential for publica-
tion bias, and found no relationship between the
study standard error and the study effect size
(p = 0.39).
Discussion
Our analysis compared the quantitative ﬁndings of
all available epidemiological studies and shows that
abdominal obesity, identiﬁed through a variety of
measures, signiﬁcantly raises the risk of type 2 diabe-
tes across a range of different ethnic groups.
Although adjustment factors varied, all the cohorts
were adjusted for age and eight were adjusted for
BMI, which we did not consider to be a measure of
abdominal obesity. This gives us added conﬁdence in
the overall conclusion that, on average, raised
abdominal obesity increases the risk of type 2 diabe-
tes more than twofold.
When we commenced our work there was no
comprehensive review examining the relationship
between measures of abdominal obesity and the inci-
dence of type 2 diabetes. When our work was com-
pleted a review addressing this issue albeit using
different methods has been published, ﬁnding similar
over all results to our own (14). Our study adds
independent conﬁrmation of the ﬁndings of that
study, but in addition provides statistical comparison
between WC and other methods of measurement
used in the studies, which is not undertaken directly
by Vazquez et al. (14).
No heterogeneity in the predictive value of differ-
ent measures of abdominal obesity was identiﬁed.
This suggests that WC (the most straightforward
measure of abdominal obesity used in the studies)
may be sufﬁcient to identify subjects at raised risk. A
similar ﬁnding has recently been reported in relation
to the risk of cardiovascular disease (CVD); Koning
et al. (15) found that a 1 cm increase in WC is associ-
ated with a 2% increase in the relative risk of future
CVD, and the difference between WC and WHR in
terms of strength of association is not signiﬁcant.
Different measures may capture different elements
of abdominal obesity. WC cannot distinguish
abdominal subcutaneous fat, total abdominal fat and
total body fat, and it is strongly correlated with BMI
(14), although it performed at least as well as the
other measures evaluated here. WC, or more usually
maximal abdominal circumference, is easily mea-
sured and can be monitored by patients themselves.
What this study demonstrates is that whatever mea-
sure is used they all show a strong relationship to
the incidence of type 2 diabetes. This ﬁnding is
important because it conﬁrms that clinicians can use
a simple measure of abdominal obesity in everyday
practice to help identify patients at increased risk of
developing type 2 diabetes.
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is biologically plausible. Abdominal fat is thought to
increase the risk of diabetes through a number of
secreted factors including non-esteriﬁed fatty acids
and adipocytokines including tumour necrosis fac-
tor-a and reduced adiponectin. Reduction in WC is
associated with an improvement in the circulating
levels of these adipose tissue secreted factors. Thus,
reducing WC may lead to a lower risk of progression
to diabetes, as has been demonstrated in some stud-
ies targeting obesity and lifestyle in those at risk of
type 2 diabetes (16,17).
As the searches for our review were undertaken, a
long-term follow up of multinational monitoring of
trends and determinants in cardiovascular disease
(MONICA) subjects examining the risk of the devel-
opment of type 2 diabetes has been published (18).
This large study also identiﬁed no difference between
WC and WHR in predicting risk, and provides further
conﬁrmation for our ﬁndings.
As a growing array of therapies offers the potential
for signiﬁcant reductions in obesity, effective target-
ing of these therapies towards those at higher risk
and with the most to beneﬁt from treatment may be
improved by the systematic measurement of WC
alongside other risk factors.
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